Long non‐coding RNAs as an epigenetic regulator in human cancers
Citations Over TimeTop 1% of 2017 papers
Abstract
Recent studies have described the important multiple roles of long non-coding RNAs (lncRNAs) during oncogenic transformation. Because the coding genome accounts for a small amount of total DNA, and many mutations leading to cancer occur in the non-coding genome, it is plausible that the dysregulation of such non-coding transcribes might also affect tumor phenotypes. Indeed, to date, lncRNAs have been reported to affect diverse biological processes through the regulation of mRNA stability, RNA splicing, chromatin structure, and miRNA-mediated gene regulation by acting as miRNA sponges. Furthermore, accumulating studies have described the roles of lncRNAs in tumorigenesis; however, the precise mechanisms of many lncRNAs are still under investigation. Here, we discuss recently reported mechanistic insights into how lncRNAs regulate gene expression and contribute to tumorigenesis through interactions with other regulatory molecules. We especially highlight the role of taurine upregulated gene 1, which was recently reported to have biological functions related to gene regulation, and discuss the future clinical implications of lncRNAs in cancer treatments.
Related Papers
- → Circulating MicroRNA and Long Noncoding RNA as Biomarkers of Cardiovascular Diseases(2015)68 cited
- → Long Noncoding RNAs in Metabolic Syndrome Related Disorders(2016)76 cited
- → The Role of Noncoding RNAs in Pituitary Adenoma(2021)9 cited
- Research of microRNA and epigenetics in Alzheimer's disease(2011)
- The dichotomy of p53 regulation by noncoding RNAs(2014)